BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.428,93 PKT +17,88 PKT +1,27 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
22.01.16 ABB (Asea Brown Boveri) Neutral UBS AG
22.01.16 Richemont Outperform Credit Suisse Group
22.01.16 Swiss Re buy Citigroup Corp.
21.01.16 Zurich Insurance Sell S&P Capital IQ
21.01.16 Zurich Insurance Sell Société Générale Group S.A. (SG)
21.01.16 Zurich Insurance buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
21.01.16 Richemont buy HSBC
21.01.16 Zurich Insurance Hold Deutsche Bank AG
21.01.16 Zurich Insurance kaufen Bankhaus Lampe KG
21.01.16 Zurich Insurance Neutral UBS AG
21.01.16 Zurich Insurance Outperform Credit Suisse Group
20.01.16 ABB (Asea Brown Boveri) Sell Goldman Sachs Group Inc.
20.01.16 Zurich Insurance Verkaufen DZ-Bank AG
19.01.16 Richemont kaufen Independent Research GmbH
19.01.16 Richemont buy UBS AG
19.01.16 Holcim Neutral UBS AG
19.01.16 Novartis buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.01.16 Swiss Re buy Société Générale Group S.A. (SG)
18.01.16 UBS buy Citigroup Corp.
18.01.16 Richemont buy Goldman Sachs Group Inc.
15.01.16 Richemont overweight Morgan Stanley
15.01.16 Richemont Outperform Bernstein Research
15.01.16 Nestlé Equal weight Barclays Capital
15.01.16 Roche overweight Barclays Capital
15.01.16 Novartis Underweight Barclays Capital
15.01.16 Richemont overweight JP Morgan Chase & Co.
15.01.16 Holcim Neutral BNP PARIBAS
14.01.16 Richemont buy S&P Capital IQ
14.01.16 UBS Outperform RBC Capital Markets
14.01.16 UBS Sell Société Générale Group S.A. (SG)
14.01.16 UBS Market Perform Cowen and Company, LLC
14.01.16 Roche buy Jefferies & Company Inc.
14.01.16 Novartis buy Jefferies & Company Inc.
14.01.16 Swiss Re Neutral Goldman Sachs Group Inc.
14.01.16 Holcim Neutral JP Morgan Chase & Co.
14.01.16 UBS Neutral Credit Suisse Group
13.01.16 UBS overweight Morgan Stanley
13.01.16 UBS overweight Morgan Stanley
13.01.16 Novartis Halten Independent Research GmbH
13.01.16 Nestlé overweight JP Morgan Chase & Co.